Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease

Movement Disorders

Volumn 10, Issue 3, 1995, Pages 337-340

  Suchowersky, Oksana ^a,b   Furtado, Sarah ^a,b   Rohs, Gina ^a,b  

^a Movement Disorders Clinic ^*  (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Desmopressin; Nocturnal polyuria; Parkinson's disease

Indexed keywords

DESMOPRESSIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HORMONAL THERAPY; HUMAN; HYPONATREMIA; INTRANASAL DRUG ADMINISTRATION; MALE; NOCTURIA; PARKINSON DISEASE; PATIENT COMPLIANCE; POLYURIA; PRIORITY JOURNAL;

ADMINISTRATION, INTRANASAL; AGED; AGED, 80 AND OVER; DEAMINO ARGININE VASOPRESSIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYURIA; SLEEP DISORDERS; URODYNAMICS;

EID: 0029066835     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.870100318     Document Type: Article

References (24)

1. Autonomic dysfunction in Parkinson's disease
2. Autonomic nervous system disorders in Parkinson's disease
3. Treatment of autonomic failure
4. Autonomic dys‐function in men with Parkinson's disease
5. Parkinson's disease: management
6. Neurogenic bladder in parkinsonism: effect of thalamotomy
7. Role of subcutaneous apomorphine in Parkinsonian voiding dysfunction
8. Effect of apomorphine on the bladder of parkinsonian patients
9. Les troubles vésico‐sphinctériens de la maladie de Parkinson
10. The treatment of autonomic dysfunction
11. Clinical experience with desmopressin: efficacy and safety in central diabetes insipidus and other conditions
12. Drug therapy for nocturnal enuresis. Current treatment and recommendations
13. Nocturnal enuresis: experience with long‐term use of intranasally administered desmopressin
14. The effect of desmopressin on nocturnal polyuria, overnight weight loss and morning postural hypotension in patients with autonomic failure
15. Dangers of intranasal desmopressin for nocturnal enuresis
16. Hyponatremic seizures in a child treated with desmopressin to control enuresis
17. Convulsions caused by deep hyponatremia during treatment of enuresis with nasal desmopressin
18. Seizure with hyponatremia in a child prescribed desmopressin for nocturnal enuresis
19. Contraction of urinary bladder by central norepinephrine originating in the locus coeruleus
20. Voiding dysfunction in Parkinson's disease
21. Cerebrospinal fluid arginine vasopressin in Parkinson's disease, dementia and other degenerative disorders
22. Evidence for dopamine as an inhibitor of vasoprotein release in man
23. Long‐term treatment of nocturnal enuresis with desmopressin. A follow‐up study
24. 40 years of being treated for nocturnal enuresis